Comparison of changes in bone mineral density and bone turnover marker with alendronate once-weekly and bi-weekly in postmenopausal Korean women

被引：0
|
作者：
Oh, H.
Joe, I.
Yu, B.
Kim, K.
机构：
[1] Cheilgen Hosp, Seoul, South Korea
[2] Kunyang Univ, Taejon, South Korea
[3] Catholic Univ, Seoul, South Korea
来源：
CALCIFIED TISSUE INTERNATIONAL | 2007年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S133 / S133
页数：1
相关论文
共 50 条
  • [31] Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: A randomized double-blind study
    Rosen, CJ
    Hochberg, MC
    Bonnick, SL
    McClung, M
    Miller, P
    Broy, S
    Kagan, R
    Chen, E
    Petruschke, RA
    Thompson, DE
    de Papp, AE
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (01) : 141 - 151
  • [32] Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis
    Chailurkit, LO
    Jongjaroenprasert, W
    Rungbunnapun, S
    Ongphiphadhanakul, B
    Sae-Tung, S
    Rajatanavin, R
    JOURNAL OF BONE AND MINERAL METABOLISM, 2003, 21 (06) : 421 - 427
  • [33] Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis
    La-or Chailurkit
    Wallaya Jongjaroenprasert
    Sasithorn Rungbunnapun
    Boonsong Ongphiphadhanakul
    Sunee Sae-tung
    Rajata Rajatanavin
    Journal of Bone and Mineral Metabolism, 2003, 21 : 421 - 427
  • [34] Once-weekly alendronate: Two-year subgroup efficacy analyses in postmenopausal women with osteoporosis
    Bone, H
    Felsenberg, D
    Greenwald, M
    Schnitzer, T
    Kaur, A
    Peverly, C
    Cudny, M
    Orloff, J
    Santora, A
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S30 - S30
  • [35] Once-weekly alendronate: Two year subgroup efficacy analyses in postmenopausal women with osteoporosis.
    Bone, H
    Felsenberg, D
    Greenwald, M
    Schnitzer, T
    Kaur, A
    Cudny, M
    Peverly, C
    Orloff, J
    Santora, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S526 - S526
  • [36] Once-weekly alendronate produces a greater decrease in bone resorption than daily risedronate
    Hosking, D
    Adami, S
    Felsenberg, D
    Reginster, JY
    Cannata, J
    Valimaki, M
    Santora, A
    Suryawanshi, S
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S14 - S15
  • [37] Reduction of type II collagen degradation in postmenopausal women with osteoporosis by alendronate once-weekly and risedronate
    Garnero, P
    Valimaki, M
    Hosking, D
    Daifotis, A
    Peverly, C
    Zaru, L
    Santora, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S16 - S17
  • [38] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
    Atmaca, Aysegul
    Gedlik, Olcay
    ADVANCES IN THERAPY, 2006, 23 (06) : 842 - 853
  • [39] Larger increases in bone mineral density with once weekly alendronate 70 mg than once weekly risedronate 35 mg in the osteoporotic subgroup of fact
    Hochberg, MC
    Bonnick, S
    Broy, S
    Chen, E
    Petruschke, RA
    De Papp, A
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 354 - +
  • [40] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
    Aysegul Atmaca
    Olcay Gedik
    Advances in Therapy, 2006, 23 : 842 - 853
12345